Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.

Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2007 Feb; 245(2):258-66.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.